What Lies Beneath the Stone? Metabolic Insights From Composition-Based Analysis of Kidney Stones
NCT ID: NCT06992206
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
506 participants
OBSERVATIONAL
2010-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Stone Composition in Surgical Kidney Stone Patients in Vietnam
NCT07038954
Are the Stone Density and Location Useful Parameters for Small Kidney Stones?
NCT03503539
Impact of Surgical Position on Stone-Free Rates in Retrograde Intrarenal Surgery
NCT06809582
The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones
NCT04071340
Comparison of Ultra-mini PCNL and Micro PCNL
NCT02522689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Serum levels of calcium, phosphorus, uric acid, creatinine, and parathyroid hormone (PTH), along with 24-hour urine values (calcium, oxalate, citrate, uric acid, volume, and pH), were recorded. The study primarily compares metabolic differences between:
First-time vs. recurrent stone formers
COM vs. COD stone subtypes
Findings from this study are expected to improve understanding of metabolic risk factors and contribute to the development of tailored metabolic evaluations and dietary or pharmacological preventive strategies for recurrent stone formers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First-time Stone Formers
Adult patients who presented with their first episode of kidney stone disease. These patients underwent stone composition analysis via FTIR spectroscopy and metabolic evaluation including serum and 24-hour urine testing to identify risk factors for initial stone formation.
Metabolik taş analizi ile retrospektif gözlem
This study did not involve an active intervention. It retrospectively analyzed medical records of 506 patients who underwent compositional analysis of kidney stones to identify metabolic abnormalities. The aim was to evaluate stone composition in relation to metabolic parameters such as serum and 24-hour urine values, without modifying patient treatment.
Recurrent Stone Formers
Patients with a documented history of recurrent kidney stone episodes. These individuals were evaluated to assess differences in metabolic profiles and stone composition compared to first-time stone formers, with the aim of identifying predictors of recurrence and optimizing preventive strategies.
Metabolik taş analizi ile retrospektif gözlem
This study did not involve an active intervention. It retrospectively analyzed medical records of 506 patients who underwent compositional analysis of kidney stones to identify metabolic abnormalities. The aim was to evaluate stone composition in relation to metabolic parameters such as serum and 24-hour urine values, without modifying patient treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metabolik taş analizi ile retrospektif gözlem
This study did not involve an active intervention. It retrospectively analyzed medical records of 506 patients who underwent compositional analysis of kidney stones to identify metabolic abnormalities. The aim was to evaluate stone composition in relation to metabolic parameters such as serum and 24-hour urine values, without modifying patient treatment.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with kidney stones between January 2010 and December 2024
* Stone composition analyzed via Fourier-transform infrared (FTIR) spectroscopy
* Available metabolic panel including serum and 24-hour urine values
Exclusion Criteria
* Patients with incomplete medical records
* Patients with non-calcium-based stones (e.g., uric acid, struvite, cystine)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hisar Intercontinental Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Basri Cakiroglu
Prof.Dr
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hisar-KSD-2025-33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.